Consolidation radiotherapy for advanced-stage aggressive B-cell non-Hodgkin lymphoma : a systematic review and meta-analysis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Consolidation radiotherapy for advanced-stage aggressive B-cell non-Hodgkin lymphoma ; Vol. 16 2017
EXCLI journal ; Vol. 16 2017
- Classification
-
Medizin, Gesundheit
- Creator
-
Yap, Ernie
Law, Zhe Kang
Aslan Abdullah, Nik Muhd
Abdul Wahid, S. Fadilah
- Handle
-
2003/36805
- URN
-
urn:nbn:de:101:1-2018060104050505423422
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:35 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Yap, Ernie
- Law, Zhe Kang
- Aslan Abdullah, Nik Muhd
- Abdul Wahid, S. Fadilah
Other Objects (12)
Cytokine expression in B-cell non-Hodgkin lymphomas
High incidence of fractures after R-CHOP-like chemotherapy for aggressive B-cell non-Hodgkin lymphomas
Primary B-cell Non-Hodgkin Lymphoma of Gallbladder Presenting as Cholecystitis
Bromodomain proteins as potential therapeutic targets for B-cell non-Hodgkin lymphoma
Non-coding RNA expression profiling of B-cell malignant (non-Hodgkin) lymphomas
Lymphozytenmigration bei Non-Hodgkin- und Hodgkin-Lymphomen
Leukemia and non-Hodgkin lymphoma
Constitutive overexpression of a novel 21 kDa protein by Hodgkin Lymphoma and Aggressive Non-Hodgkin Lymphomas
Combination of acalabrutinib with lenalidomide and rituximab in relapsed/refractory aggressive B-cell non-Hodgkin lymphoma: a single-arm phase II trial
Serum Free Light Chain Assay as a Prognostic Marker in Patients with Aggressive B-Cell Non-Hodgkin's Lymphoma: Impact on Survival Outcome
Aggressive B-cell non-Hodgkin lymphomas: a report of the lymphoma workshop of the 20th meeting of the European Association for Haematopathology
Efficacy and safety of lenalidomide in the treatment of B-cell non-Hodgkin lymphoma
Cytokine expression in B-cell non-Hodgkin lymphomas
High incidence of fractures after R-CHOP-like chemotherapy for aggressive B-cell non-Hodgkin lymphomas
Primary B-cell Non-Hodgkin Lymphoma of Gallbladder Presenting as Cholecystitis
Bromodomain proteins as potential therapeutic targets for B-cell non-Hodgkin lymphoma
Non-coding RNA expression profiling of B-cell malignant (non-Hodgkin) lymphomas
Lymphozytenmigration bei Non-Hodgkin- und Hodgkin-Lymphomen
Leukemia and non-Hodgkin lymphoma
Constitutive overexpression of a novel 21 kDa protein by Hodgkin Lymphoma and Aggressive Non-Hodgkin Lymphomas
Combination of acalabrutinib with lenalidomide and rituximab in relapsed/refractory aggressive B-cell non-Hodgkin lymphoma: a single-arm phase II trial
Serum Free Light Chain Assay as a Prognostic Marker in Patients with Aggressive B-Cell Non-Hodgkin's Lymphoma: Impact on Survival Outcome
Aggressive B-cell non-Hodgkin lymphomas: a report of the lymphoma workshop of the 20th meeting of the European Association for Haematopathology
Efficacy and safety of lenalidomide in the treatment of B-cell non-Hodgkin lymphoma
Cytokine expression in B-cell non-Hodgkin lymphomas
High incidence of fractures after R-CHOP-like chemotherapy for aggressive B-cell non-Hodgkin lymphomas
Primary B-cell Non-Hodgkin Lymphoma of Gallbladder Presenting as Cholecystitis
Bromodomain proteins as potential therapeutic targets for B-cell non-Hodgkin lymphoma
Non-coding RNA expression profiling of B-cell malignant (non-Hodgkin) lymphomas
Lymphozytenmigration bei Non-Hodgkin- und Hodgkin-Lymphomen
Leukemia and non-Hodgkin lymphoma
Constitutive overexpression of a novel 21 kDa protein by Hodgkin Lymphoma and Aggressive Non-Hodgkin Lymphomas
Combination of acalabrutinib with lenalidomide and rituximab in relapsed/refractory aggressive B-cell non-Hodgkin lymphoma: a single-arm phase II trial
Serum Free Light Chain Assay as a Prognostic Marker in Patients with Aggressive B-Cell Non-Hodgkin's Lymphoma: Impact on Survival Outcome
Aggressive B-cell non-Hodgkin lymphomas: a report of the lymphoma workshop of the 20th meeting of the European Association for Haematopathology